1 active not recruiting, 1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Carcinoma, Giant Cell: new trials by email Literature Review of Carcinoma, Giant Cell trials Research Report on Carcinoma, Giant Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Erlotinib, Carboplatin, Paclitaxel - Non-Small Cell Lung Cancer, Lung Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 68 | 2007-11-01 | 2019-11-20 |
| Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma Carcinoma, Giant Cell, Carcinoma, Non-Small-Cell Lung | Terminated | Stanford University | 129 | 2002-02-01 | 2019-05-02 |
Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Adenocarcinoma (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenocarcinoma, Clear Cell (1) · Adenocarcinoma, Mucinous (1) · Adrenocortical Carcinoma (1) · Bile Duct Neoplasms (1) · Carcinoma, Acinar Cell (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Basal Cell (1) · Carcinoma, Endometrioid (1) · Carcinoma, Squamous Cell (1) · Carcinoma, Transitional Cell (1)
Carcinoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Adenocarcinoma (1) · Adenocarcinoma of Lung (1) · Adnexal Diseases (1) · Adrenal Cortex Diseases (1)
CTLA-4 Antigen (1) · Carboplatin (1) · Erlotinib Hydrochloride (1) · Ipilimumab (1) · Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · Paclitaxel (1) · Radiotherapy (1) · Specimen Handling (1)
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Stanford University (1)
United States (3) · Guam (1)
Daya Upadhyay (1) · Glenn D. Rosen (1) · Sandip P Patel (1) · Steven H. Lin, MD, PHD (1)
PMID 25968826, PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
U10CA180888 (1)